Cite

HARVARD Citation

    Navada, S. et al. (n.d.). Combination of Oral Rigosertib and Injectable Azacitidine in Patients with Myelodysplastic Syndromes (MDS). Leukemia research. pp. S30-. [Online]. 
  
Back to record